Cargando…
Neurochondrin neurological autoimmunity
OBJECTIVES: To describe the neurologic spectrum and treatment outcomes for neurochondrin-IgG positive cases identified serologically in the Mayo Clinic Neuroimmunology Laboratory. METHODS: Archived serum and CSF specimens previously scored positive for IgGs that stained mouse hippocampal tissue in a...
Autores principales: | Shelly, Shahar, Kryzer, Thomas J., Komorowski, Lars, Miske, Ramona, Anderson, Mark D., Flanagan, Eoin P., Hinson, Shannon R., Lennon, Vanda A., Pittock, Sean J., McKeon, Andrew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745726/ https://www.ncbi.nlm.nih.gov/pubmed/31511329 http://dx.doi.org/10.1212/NXI.0000000000000612 |
Ejemplares similares
-
ITPR1 autoimmunity: Frequency, neurologic phenotype, and cancer association
por: Alfugham, Nora, et al.
Publicado: (2017) -
Contactin-1 autoimmunity: Serologic, neurologic, and pathologic correlates
por: Dubey, Divyanshu, et al.
Publicado: (2020) -
Autoimmune gait disturbance accompanying adaptor protein-3B2-IgG
por: Honorat, Josephe A., et al.
Publicado: (2019) -
Phosphodiesterase 10A IgG: A novel biomarker of paraneoplastic neurologic autoimmunity
por: Zekeridou, Anastasia, et al.
Publicado: (2019) -
Neurochondrin is a neuronal target antigen in autoimmune cerebellar degeneration
por: Miske, Ramona, et al.
Publicado: (2016)